It’s no secret that patient retention is one of the many challenges a ClinOps leader and their team faces, as they drive studies to success. This is a battle that is typically taken up once a patient has already enrolled onto a study; we think it can be considered a lot earlier than that.  From… Continue reading Protecting Patient Retention Rates in a Clinical Trial Starts Earlier Than You Think

In our previous blog post, we talked about the impact of clinical trial timeline delays on patient communities and our Pharma partners.  Today we’re covering some of the main delay red flags, and how we problem-solve to protect our clients from facing study delays – typically saving 6-12 months per study. First: what causes timeline… Continue reading The Growing Burden Study Timelines for Our Pharma Partners: How We Spot the Red Flags and Problem-Solve in Real-Time

For our Pharma partners, keeping research timelines on track is just one of countless important items they have to balance. It’s not an industry secret that between 30-80% of clinical trials suffer delays, which impacts research and patients in a number of ways. The knock-on effects cause potential new treatments to take longer to reach… Continue reading The Growing Study Timelines Burden for Our Pharma Partners: What Is the Real Impact?

If I were to summarize 2022 at Leapcure, it would be the year of building foundations that support our growth. This year, our team: This mission solidifies what we have believed for years; that clinical research must focus on incorporating diverse patient voices that allows for the development of novel therapies that serve everyone. We… Continue reading 2022 at Leapcure: Reflections from Leadership